ORTINGLOBE

ORTIN GLOBAL LIMITED

Pharmaceutical company manufacturing drugs and medicines

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

ortinlabsindia.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹14.34
Market cap
12 Cr
Stock P/E
Loss (TTM EPS ₹-1.12)
P/B
9.43
ROE (FY26)
-59.8%
ROCE (FY26)
-32.2%
Operating margin (FY26)
-1030.5%
Debt / equity (FY26)
0.81
OCF / EBITDA (FY23)
-41.8%
OCF / EBITDA (3Y)
930.6%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Ortin Global is a small Hyderabad-based pharmaceutical company that reports a single business segment.

Company snapshot

119thBy market cap

Ranked among 119 companies in Pharmaceuticals.

What we see

Positives
  • ✓931% of operating profit came in as cash over the last three years — profits are backed by real cash.
Concerns
  • ✗Net margin is negative — the company is spending more than it earns right now.
2 more signals from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales0.26 Cr0.14 Cr0.14 Cr0.21 Cr0.05 Cr0.03 Cr0.05 Cr0.04 Cr0.01 Cr0.01 Cr0.03 Cr0.01 Cr
Operating expenses (approx.)1 Cr3 Cr3 Cr0.31 Cr0.50 Cr0.17 Cr0.25 Cr0.24 Cr0.52 Cr0.06 Cr0.32 Cr0.35 Cr
EBITDA-0.90 Cr-3 Cr-3 Cr-0.10 Cr-0.45 Cr-0.13 Cr-0.20 Cr-0.20 Cr-0.50 Cr-0.05 Cr-0.28 Cr-0.34 Cr
OPM %-347.3%-1912.4%-2222.4%-47.5%-820.3%-397.3%-445.9%-511.6%-3581.4%-401.6%-816.3%-2919.8%
Other income0.0057 Cr0.0007 Cr0.16 Cr0.0026 Cr-0.0023 Cr0 Cr0.04 Cr0.04 Cr0 Cr0 Cr0.27 Cr0.0044 Cr
Interest0.15 Cr0.14 Cr0.08 Cr0.0001 Cr0.02 Cr-0.01 Cr0.0002 Cr0.0004 Cr0.0011 Cr-0.0005 Cr0.0012 Cr0 Cr
Depreciation0.06 Cr0.06 Cr0.05 Cr0.0048 Cr0.0048 Cr0.0021 Cr0 Cr0 Cr0.0001 Cr0.0001 Cr0.0003 Cr0.0003 Cr
Profit before tax-1 Cr-3 Cr-3 Cr-0.10 Cr-0.47 Cr-0.10 Cr-0.16 Cr-0.16 Cr-0.50 Cr-0.05 Cr-0.0089 Cr-0.33 Cr
Tax %-1.4%0.6%-30.4%-1.7%0.3%-5.4%-1.8%-7.7%0.0%-8.6%-4.5%-1.0%
Net profit-1 Cr-3 Cr-4 Cr-0.10 Cr-0.47 Cr-0.11 Cr-0.16 Cr-0.18 Cr-0.50 Cr-0.05 Cr-0.0093 Cr-0.34 Cr
EPS (₹)₹-1.38₹-3.43₹-5.10₹-0.13₹-0.58₹-0.13₹-0.20₹-0.22₹-0.62₹-0.07₹-0.01₹-0.42

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales168 Cr197 Cr8 Cr8 Cr6 Cr2 Cr0.34 Cr0.10 CrSign in free for the trailing twelve months
Operating expenses (approx.)161 Cr192 Cr7 Cr8 Cr5 Cr9 Cr1 Cr1 CrSign in free for the trailing twelve months
EBITDA7 Cr6 Cr1 Cr0.38 Cr0.52 Cr-7 Cr-0.88 Cr-1 CrSign in free for the trailing twelve months
OPM %4.0%2.9%15.2%4.6%8.6%-309.6%-258.2%-1030.0%Sign in free for the trailing twelve months
Other income0.13 Cr0.17 Cr0.05 Cr0.19 Cr0.04 Cr0.17 Cr0.04 Cr0.31 CrSign in free for the trailing twelve months
Interest3 Cr3 Cr0.87 Cr0.81 Cr0.40 Cr0.48 Cr0.0027 Cr0.0022 CrSign in free for the trailing twelve months
Depreciation2 Cr2 Cr0.29 Cr0.29 Cr0.25 Cr0.23 Cr0.01 Cr0.0005 CrSign in free for the trailing twelve months
Profit before tax2 Cr0.72 Cr0.14 Cr-0.53 Cr-0.08 Cr-7 Cr-0.84 Cr-0.72 CrSign in free for the trailing twelve months
Tax %30.4%178.5%-593.1%24.8%20.2%-13.7%-1.1%-2.4%Sign in free for the trailing twelve months
Net profit1 Cr-0.56 Cr0.95 Cr-0.40 Cr-0.07 Cr-8 Cr-0.85 Cr-0.74 CrSign in free for the trailing twelve months
EPS (₹)₹0.76₹-0.33₹1.16₹-0.49₹-0.08₹-9.89₹-1.04₹-0.91Sign in free for the trailing twelve months
Dividend payout %——0.0%—————Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital17 Cr17 Cr8 Cr8 Cr8 Cr8 Cr8 Cr8 Cr
Reserves8 Cr7 Cr3 Cr3 Cr3 Cr-5 Cr-6 Cr-7 Cr
Borrowings19 Cr20 Cr7 Cr6 Cr6 Cr2 Cr0.25 Cr1 Cr
Other liabilities61 Cr73 Cr3 Cr4 Cr4 Cr2 Cr2 Cr2 Cr
Total liabilities105 Cr117 Cr21 Cr21 Cr21 Cr7 Cr4 Cr5 Cr
Fixed assets (net)21 Cr22 Cr14 Cr14 Cr14 Cr0.01 Cr0.0036 Cr0.0050 Cr
CWIP0.53 Cr0.43 Cr0.43 Cr0.43 Cr0.43 Cr——0 Cr
Investments0.08 Cr0.07 Cr0 Cr0 Cr0 Cr0 Cr0 Cr0 Cr
Inventories37 Cr50 Cr2 Cr2 Cr3 Cr0.05 Cr0.02 Cr0 Cr
Trade receivables38 Cr37 Cr4 Cr3 Cr3 Cr2 Cr0.26 Cr0.20 Cr
Cash & bank0.89 Cr0.95 Cr0.03 Cr0.49 Cr0.22 Cr0.46 Cr0.37 Cr0.61 Cr
Other assets8 Cr6 Cr0.69 Cr0.60 Cr0.57 Cr4 Cr3 Cr4 Cr
Total assets105 Cr117 Cr21 Cr21 Cr21 Cr7 Cr4 Cr5 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity7 Cr6 Cr18 Cr2 Cr-0.22 Cr-4 Cr-0.41 Cr-0.56 Cr
Cash from investing-3 Cr-3 Cr0.07 Cr-0.13 Cr-0.0020 Cr12 Cr-0.0036 Cr0.04 Cr
Cash from financing-3 Cr-4 Cr-8 Cr-0.48 Cr0.90 Cr-3 Cr0.33 Cr0.75 Cr
Net cash flow0.37 Cr-1 Cr-4 Cr2 Cr0.68 Cr4 Cr-0.09 Cr0.23 Cr
Free cash flow (OCF − Capex)3 Cr3 Cr18 Cr2 Cr-0.22 Cr-4 Cr-0.41 Cr-0.56 Cr

Ratios

MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %11.3%9.1%5.5%1.6%1.8%-142.5%-37.5%-32.2%
ROE %5.1%-2.4%8.3%-3.6%-0.6%-284.7%-42.8%-59.8%
Debtor days8269174143207305278726
Inventory days951101631382438390
Days payable122133119621451284182
Cash conversion cycle5546219218305301233544
OCF / EBITDA %97.6%n.m.1448.3%566.6%-41.8%———
OCF / EBITDA % (3 years)——225.8%360.2%930.6%———
Debt / equity0.780.820.610.560.590.640.130.81
Current ratio1.141.100.780.760.943.112.391.60
Net debt / EBITDA2.783.26——11.96———